ÂÜÀòÂÒÂ×

William Kim, PharmD, MBA has a diverse background with experience in the pharmaceutical industry as well as academic research. William is currently serving as the Vice President of Market Access for Oncology at Eagle Pharmaceuticals, Inc. Prior to this role, William worked at Novartis as an Executive Director, leading market access efforts for the neuroscience portfolio and COVID pipeline asset. William also held positions at Celgene, where they were responsible for access marketing for the immunology and neurology portfolio, and at Sanofi, where they held various roles including Director of Strategic Pricing & Contracting and Director of US Market Access Strategy. Additionally, William has experience in academia as an Adjunct Faculty member at Rutgers University and as a Research Assistant. During the early years of their career, they worked as a Pharmacy Technician at various retail and community pharmacies.

William Kim holds a Doctor of Pharmacy (Pharm.D.) degree from Rutgers University. William also obtained their Master of Business Administration (MBA) degree from The Wharton School. In terms of additional certifications, they have achieved the credentials of Delivering Medication Therapy Management (MTM) Services from the American Pharmacists Association in September 2014, and as a Registered Pharmacist (RPh) from the State of New Jersey Office of the Attorney General in May 2013.